Report overview
This report contains market size and forecasts of RNA In Situ Hybridization in Global, including the following market information:
Global RNA In Situ Hybridization Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global RNA In Situ Hybridization market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GISH Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNA In Situ Hybridization include Abbott, Biogenex, Biosb, Roche, Sigma-Aldrich, Advanced Cell Diagnostics, Affymetrix, Exiqon and Agilent Technologies and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNA In Situ Hybridization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA In Situ Hybridization Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global RNA In Situ Hybridization Market Segment Percentages, by Type, 2021 (%)
GISH
FISH
mFISH
PCR
Global RNA In Situ Hybridization Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global RNA In Situ Hybridization Market Segment Percentages, by Application, 2021 (%)
Hospitals
Pharma & Biotech Companies
Research Labs
CROs
Global RNA In Situ Hybridization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global RNA In Situ Hybridization Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA In Situ Hybridization revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies RNA In Situ Hybridization revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Biogenex
Biosb
Roche
Sigma-Aldrich
Advanced Cell Diagnostics
Affymetrix
Exiqon
Agilent Technologies
Thermo Fisher Scientific
